‘March In’ Plan Unveiled By Democratic Think Tank: A Battle Biopharma Would Welcome?

In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.

The Center for American Progress’ newly unveiled proposal for immediate action on drug pricing for a Joe Biden Administration shows how dramatically the pricing debate has changed over the past four years.

CAP is seeking to reprise the role it played for the Hillary Clinton Presidential campaign in 2015-2016, outlining strategies for a Democratic candidate to embrace and prepare

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access